Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bell's Back & Muscle Pain Relief 200mg capsules
1001010J0DMABAA
|
Bell's (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Bell's Children's Pain & Fever Relief 100mg/5ml susp
1001010J0DMAABH
|
Bell's (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Bell's Muscle Rub ointment
1003020N0BUABA0
|
Bell's (Methyl salicylate) | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Bell's Seven in One Rubbing Oil
1003020N0BUAABB
|
Bell's (Methyl salicylate) | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Benemid 500mg tablets (Imported)
1001040K0BFAAAA
|
Benemid (Imported) | Probenecid | Musculoskeletal and Joint Diseases | No data available |
|
Benemid 500mg tablets (Merck Sharp & Dohme Ltd)
1001040K0BBAAAA
|
Benemid (MSD) | Probenecid | Musculoskeletal and Joint Diseases | No data available |
|
Benepali 25mg/0.5ml inj pre-filled syringes
1001030D0BCACAD
|
Benepali | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Benlysta 120mg pdr for concentrate for inf vials
1001030Z0BBAAAA
|
Benlysta | Belimumab | Musculoskeletal and Joint Diseases | No data available |
|
Benlysta 400mg pdr for concentrate for inf vials
1001030Z0BBABAB
|
Benlysta | Belimumab | Musculoskeletal and Joint Diseases | No data available |
|
Benoral 2g granules sachets
1001010H0BBABAA
|
Benoral | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Benoral 2g/5ml oral suspension
1001010H0BBACAD
|
Benoral | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Benoral 750mg tablets
1001010H0BBAAAC
|
Benoral | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Benorilate 2g granules sachets sugar free
1001010H0AAAAAA
|
Benorilate | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Benorilate 2g/5ml oral suspension sugar free
1001010H0AAADAD
|
Benorilate | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Benorilate 750mg tablets
1001010H0AAACAC
|
Benorilate | Benorilate | Musculoskeletal and Joint Diseases | No data available |
|
Berlind 75 Retard capsules
1001010K0BXAAAD
|
Berlind | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Bextra 10mg tablets
1001010ALBBAAAA
|
Bextra | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Bextra 20mg tablets
1001010ALBBABAB
|
Bextra | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Bextra 40mg tablets
1001010ALBBACAC
|
Bextra | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Bio-Health Glucosamine hydrochloride 600mg capsules
1001050A0BFAFAP
|
Glucosamine hydrochloride (Compound preparations) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Boots Ibuprofen 3 Months Plus 100mg/5ml susp strawberry
1001010J0CFACBH
|
Boots ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Boots Ibuprofen 6 Months Plus 100mg/5ml susp strawberry
1001010J0CFABBH
|
Boots ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Boots Ibuprofen and Codeine 200mg/12.8mg tablets
1001010J0CFADAY
|
Boots ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Boots Ibuprofen Long Lasting 200mg capsules
1001010J0CFAEBA
|
Boots ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Boots Ibuprofen Max Strength 10% gel
1003020P0BPADAI
|
Boots (Topical ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.